Related Experiment Videos
Anticonvulsant effect of fluoxetine in humans
E Favale1, V Rubino, P Mainardi
1Institute of Clinical Neurology, Genoa University, Italy.
Neurology
|October 1, 1995
Abstract:
We report an unblinded, open-label, add-on trial of fluoxetine, a selective serotonin reuptake inhibitor, in 17 patients with complex partial seizures with and without secondary generalization (mean follow-up duration, 14 +/- 1.1 months). Six patients showed complete disappearance of their daily seizures; in the others the seizure frequency was lowered by 30%. No patient reported side effects.